Showing results (81-90 of 685) with videos related to

Sort By:
Pageof 69
Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association|October 9, 2020
Laxative use in patients with advanced chronic kidney disease transitioning to dialysisKeiichi Sumida, Ankur A Dashputre, Praveen K Potukuchi, et al.
American Journal of Nephrology|January 27, 2025
The Association of Niacin Use with Kidney Outcomes and MortalityRina Takahashi, Thuy-Anh Bui, Ibrahim Elali, et al.
Saudi Journal of Kidney Diseases and Transplantation : an Official Publication of the Saudi Center for Organ Transplantation, Saudi Arabia|March 30, 2017
Obesity and kidney disease: Hidden consequences of the epidemicCsaba P Kovesdy, Susan Furth, Carmine Zoccali, et al.
Iranian Journal of Kidney Diseases|March 9, 2017
Obesity and Kidney Disease: Hidden Consequences of the EpidemicCsaba P Kovesdy, Susan Furth, Carmine Zoccali, et al.
Revista Medica De Chile|May 27, 2017
Obesity and kidney disease: hidden consequences of the epidemicCsaba P Kovesdy, Susan Furth, Carmine Zoccali
Kidney International Reports|June 2, 2018
Abrupt Decline in Kidney Function Precipitating Initiation of Chronic Renal Replacement TherapyCsaba P Kovesdy, Adnan Naseer, Keiichi Sumida, et al.
The American Journal of Medicine|April 25, 2020
Longer Predialysis ACEi/ARB Utilization Is Associated With Reduced Postdialysis MortalityElvira O Gosmanova, Miklos Z Molnar, Adnan Naseer, et al.
Journal of Managed Care & Specialty Pharmacy|October 1, 2021
Association of dyskalemias with short-term health care utilization in patients with advanced CKDAnkur A Dashputre, Justin Gatwood, Keiichi Sumida, et al.
American Journal of Nephrology|July 21, 2021
Association of Dyskalemias with Ischemic Stroke in Advanced Chronic Kidney Disease Patients Transitioning to DialysisAnkur A Dashputre, Keiichi Sumida, Fridtjof Thomas, et al.
Lancet Regional Health. Americas|July 12, 2024
Safety of SGLT2 inhibitors, DPP-4 inhibitors, and GLP-1 receptor agonists in US veterans with and without chronic kidney disease: a population-based studyYoko Narasaki, Csaba P Kovesdy, Amy S You, et al.
Pageof 69